For Students
Science & Tech
Alzheimer disease
pathology
Category:
Science & Tech
- Key People:
- Michal Schwartz
Recent News
Mar. 8, 2024, 11:44 AM ET (AP)
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
Alzheimer disease, degenerative brain disorder that develops in mid-to-late adulthood. It results in a progressive and irreversible decline in memory and a deterioration of various other cognitive abilities. The disease is characterized by the destruction of nerve cells and neural connections in the cerebral cortex of the brain and by a significant loss of brain mass. The disease was first described in 1906 by German neuropathologist Alois Alzheimer. By the early 21st century it was recognized as the most common form of dementia among older persons. An estimated 47.5 million people worldwide were living with dementia in 2016; that figure ...(100 of 2344 words)